-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Keyuan News
03
2026-01
The first-quarter bugle has sounded, and the drums of marketing are resounding throughout the land. On January 3, Keyuan Pharmaceutical (stock code: 301281.SZ) and Linuo Pharmaceutical successfully held their 2025 Marketing Summary Meeting and 2026 First-Quarter Kickoff Rally. Centered around the theme “Reviewing the Past, Seizing the First Quarter,” the meeting comprehensively summarized past achievements, set its sights on securing a strong start to the first quarter, and aimed to achieve new growth for the entire year.
2026-01-03
31
2025-12
Time refines craftsmanship, and the passage of years witnesses transformation. As the calendar for 2025 has already turned, this year has marked a pivotal milestone for Keyuan Pharmaceutical—a year of strategic upgrading, technological leaps, and industrial integration. Guided by our “Five-Year Vision,” we’ve harnessed the dual-engine of “chemical drugs + biologics” as our driving force and leveraged digital and intelligent transformation powered by “AI + computing power” as our wings. On the journey to safeguard human health, we’ve delivered an impressive, inspiring, and highly valuable annual report card.
2025-12-31
31
2025-12
Keyuan Pharmaceutical & Linuo Pharmaceutical: The 2025 Development Report
Time refines our original aspirations, and the passage of years engraves our path forward. As the year 2025 quietly comes to a close, Keyuan Pharmaceutical and Linuo Pharmaceutical, guided by the “Five Major Founding Principles” strategy, are steadily and confidently forging ahead on the journey of pharmaceutical and healthcare innovation—using industry as their foundation and craftsmanship as their ink—to compose a grand narrative of development that resonates with the times and walks hand in hand with life itself.
2025-12-31
31
2025-12
Read good books, welcome the New Year, and embark on a new journey.
A collection of箴言 gathers in Quancheng, and seven virtuous habits unlock the talents of tomorrow. On December 31—the very eve of the year’s end—Keyuan Pharmaceutical (stock code: 301281.SZ) Marketing Center concluded 2025 on a high note with a book-sharing session on “The 7 Habits of Highly Effective People.”
2025-12-31
27
2025-12
Together in unity, we join forces and set sail for a new journey! To enrich employees’ spiritual and cultural lives, enhance their physical fitness, strengthen team cohesion, and help the company achieve its annual business targets with flying colors, on December 27, Keyuan Pharmaceutical (stock code: 301281.SZ) kicked off its 7th “Together in Unity, Gathering Strength for the Future” health walking event in a warm and uplifting atmosphere. The company’s management team, along with nearly 200 employees from various functional departments and frontline production teams, enthusiastically embarked on this hiking journey brimming with solidarity and determination.
2025-12-27
19
2025-11
According to the "Measures for Public Participation in Environmental Impact Assessment" (Ministry of Ecology and Environment Order No. 4), "Article 20: Before submitting the environmental impact report for approval to the ecological and environmental authorities, the project proponent shall publicly disclose the full text of the draft environmental impact report and the public participation statement via an online platform."
2025-11-19
18
2025-11
Shandong Keyuan Pharmaceutical Co., Ltd. has completed the Environmental Impact Assessment Report (Draft for Comments) of its Intelligent Pilot-Scale Platform Project for Specialty and Innovative Active Pharmaceutical Ingredients.
2025-11-18
18
2025-11
On November 18, the award ceremony for the "2024-2025 Family Essential Medicines List Brand" event—hosted by Family Doctor Online—concluded successfully during the Autumn Nanjing exhibition of the 91st National Pharmaceutical Fair. Recognized as an authoritative benchmark in the field of family health and medicine, the event is hailed within the industry as the "leading indicator for essential healthcare products families should consider." All brands selected for the list underwent rigorous multi-stage screening processes, including eligibility checks, market research, public voting, and expert evaluations, ensuring both the quality and reputation of the featured products while also aiming to provide consumers with a scientifically sound guide for building their household medicine kits.
2025-11-18
09
2025-10
From October 7 to 8, Shandong Keyuan Pharmaceutical Co., Ltd. (stock code: 301281.SZ) held a grand marketing-focused work conference. The meeting was themed "Charge Full Speed into the Fourth Quarter—Win the Closing Battle!" and featured a comprehensive review of the company's performance from January to September, along with strategic planning for the fourth quarter and beyond, ensuring the successful achievement of this year's business objectives. Chairman and President Gao Chunpo, Executive Vice President Ren Guangqiang, heads of various departmental centers, plant directors, and all members of the Marketing Center attended the event.
2025-10-09
28
2025-09
On September 28, the grand inauguration ceremony for the AI+Computing Power Intelligent Factory of Linuo Pharmaceutical Injection Project, a wholly-owned subsidiary of Keyuan Pharmaceutical (stock code: 301281.SZ), was held solemnly in Jinan. Over 100 guests attended the event, including representatives from Jinan Municipal Market Supervision Administration, Municipal Bureau of Industry and Information Technology, Municipal Bureau of Commerce, Municipal Bureau of Science and Technology, as well as officials from Licheng District Government and local subdistrict offices. Also present were renowned experts and scholars from the pharmaceutical industry, along with representatives from upstream and downstream partner companies, financial institutions, and media outlets—everyone gathered to witness Keyuan Pharmaceutical & Linuo Pharmaceutical’s groundbreaking achievement in the field of intelligent manufacturing for injectables.
2025-09-28
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline